Sotigalimab (Anti-TNFRSF5 / CD40)

Sotigalimab (Anti-TNFRSF5 / CD40) is an agonistic monoclonal antibody targeting CD40. It can be used for the research of metastatic pancreatic adenocarcinoma.MW :144.54 KD.
Supplier Selleck Chemicals
Product # A2635
Sku # A2635-1mg*5
Pricing 1mg*5, $970.00
Feedback